Abstract
The effects of multipotent mesenchymal stromal cell (MMSC) derivatives on breast cancer cells have been studied in vitro and in vivo. A cytostatic effect of substances produced by human bone marrow MMSCs on the tumor cell population and the inhibition of tumor cell migration into the suspension fraction in vitro were demonstrated. These phenomena were accompanied by upregulation of tumor-associated marker expression: cytokeratin and EpCAM expression was upregulated in 2D and 3D cell cultures and vimentin expression was upregulated in 3D cultures. A single injection of mouse bone marrow MMSC lysate into the experimental animals suppressed tumor growth in thigh muscles. Moreover, this treatment contributed to the preservation of muscle tissue integrity and the normalization of biochemical parameters of the blood in animals that received grafts of Ehrlich adenocarcinoma tumor cells.
Similar content being viewed by others
References
Albini, A., Bruno, A., Gallo, C., Pajardi, G., Noonan, D.M., and Dallaglio, K., Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity, Connect. Tissue Res., 2015, vol. 56, no. 5, pp. 414–225. doi 10.3109/03008207.2015.1066780
Soysal, S.D., Tzankov, A., and Muenst, S.E., Role of the tumor microenvironment in breast cancer, Pathobiology, 2015, vol. 82, nos. 3–4, pp. 142–152. doi 10.1159/000430499
Pein, M. and Oskarsson, T., Microenvironment in metastasis: roadblocks and supportive niche, Am. J. Physiol. Cell Physiol., 2015, vol. 309, no. 10, pp. 627–638. doi 10.1152/ajpcell.00145.2015
Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., Richardson, A.L., Polyak, K., Tubo, R., and Weinberg, R.A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 2007, vol. 449, no. 7162, pp. 557–563. doi 10.1038/nature06188
Hematti, P. and Keating, A., Mesenchymal Stromal Cells: Biology and Clinical Applications, London: Humana, 2013, pp. 3–16.
Zhang, C., Yang, S.-J., Wen, Q., Zhong, J.F., Chen, X.-L., Stucky, A., Press, M.F., and Zhang, X., Human-derived normal mesenchymal stem/stromal cells in anticancer therapies, J. Cancer, 2017, vol. 8, no. 1, pp. 85–96. doi 10.7150/jca.16792
Seke, E.P., Vecchio, L., and Nwabo, K.A., Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment, Cell Signal., 2012, vol. 24, no. 9, pp. 1883–1888. doi 10.1016/j.cellsig.2012.05.015
Mirsha, P.J. and Merlino, G., A traitor in our midst: mesenchymal stem cells contribute to tumor progression and metastasis, Future Oncol., 2008, vol. 4, no. 6, pp. 745–749. doi 10.2217/14796694.4.6.745
Pacioni, S., D’Alessandris Q.G., Giannetti S., Morgante L., Cocce V., Bonomi A., Buccarelli M., Pascucci L., Alessandri G., Pessina A., Ricci-Vitiani L., Falchetti M.L., Pallini R. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts, Stem. Cell Res. Ther., 2017, vol. 8, no. 1. doi 10.1186/s13287-017-0516-3
Klopp, A.H., Gupta, A., Spaeth, E., Andreeff, M., and Marini, F., 3rd, Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?, Stem. Cells, 2011, vol. 29, no. 1, pp. 11–19. doi 10.1002/stem.559
Ohlsson, L.B., Varas, L., Kjellman, C., Edvardsen, K., and Lindvall, M., Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix, Exp. Mol. Pathol., 2003, vol. 75, no. 3, pp. 248–255.
Otsu, K., Das S., Houser S.D., Quadri S.K., Bhattacharya S., Bhattacharya J. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells, Blood, 2009, vol. 113, no. 18, pp. 4197–205. doi 10.1182/blood-2008-09-176198
Khakoo, A.Y., Pati, S., Anderson, S.A., Reid, W., Elshal, M.F, Rovira, I.I., Nguyen, A.T., Malide, D., Combs, C.A., Hall, G., Zhang, J., Raffeld, M., Rogers, T.B., Stetler-Stevenson, W., Frank, J.A., Reitz, M., and Finkel, T., Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma, J. Exp. Med., 2006, vol. 203, no. 5, pp. 1235–47.
Dasari, V.R., Kaur, K., Velpula, K.K., Gujrati, M., Fassett, D., Klopfenstein, J.D., Dinh, D.H., and Rao, J.S., Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway, PLoS One, 2010, vol. 5, no. 4. e10350.
Dasari, V.R., Velpula, K.K., Kaur, K., Fassett, D., Klopfenstein, J.D., Dinh, D.H., Gujrati, M., and Rao, J.S., Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP), PLoS One, 2010, vol. 5, no. 7. e11813. doi 10.1371/journal.pone.0011813
Lu, Y.R., Yuan, Y., Wang, X.J., Wei, L.L., Chen, Y.N., Cong, C., Li, S.F., Long, D., Tan, W.D., Mao, Y.Q., Zhang, J., Li, Y.P., and Cheng, J.Q., The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo, Cancer Biol. Ther., 2008, vol. 7, no. 2, pp. 245–51.
Ma, Y., Hao, X., Zhang, S., and Zhang, J., The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells, Breast Cancer Res. Treat., 2011, vol. 133, no. 2, pp. 473–485. doi 10.1007/s10549-011-1774-x
Melzer, C., Yang, Y., and Hass, R., Interaction of MSC with tumor cells, Cell Commun. Signal., 2016, vol. 14, no. 1. doi 10.1186/s12964-016-0143-0
Trivanovic, D., Krstic, J., Djordjevic, I.O., Mojsilovic, S., Santibanez, J.F., Bugarski, D., and Jaukovic, A., The roles of mesenchymal stromal/stem cells in tumor microenvironment associated with inflammation, Mediators Inflamm., 2016, vol. 2016, pp. 1–14. doi.org/doi 10.1155/2016/7314016
Zhu, W., Xu, W., Jiang, R., Qian, H., Chen, M., Hu, J., Cao, W., Han, C., and Chen, Y., Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo, Exp. Mol. Pathol., 2006, vol. 80, no. 3, pp. 267–274. doi 10.1016/j.yexmp.2005.07.004
Hass, R. and Otte, A., Mesenchymal stem cells as allround supporters in a normal and neoplastic microenvironment, Cell Commun. Signal., 2012, vol. 10, no. 1. doi 10.1186/1478-811X-10-26
Hui, L. and Chen, Y., Tumor microenvironment: sanctuary of the devil, Cancer Lett., 2015, vol. 368, no. 1, pp. 7–13. doi 10.1016/j.canlet.2015.07.039
Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., and Keating, A., Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement, Cytotherapy, 2005, vol. 7, no. 5, pp. 393–395. doi 10.1080/14653240500319234
Bjerkvig, R., Spheroid Culture in Cancer Research, London: Taylor & Francis, 1991.
Marcucci, F., Stassi, G., and DeMaria, R., Opinion: epithelial–mesenchymal transition: new target in anticancer drug discovery, Nat. Rev. Drug. Discov., 2016, vol. 15, no. 5, pp. 311–325. doi 10.1038/nrd.2015.13
Thiery, J.P., TeckLim C., Tumor dissemination: an EMT affair, Cancer Cell, 2013, vol. 23, no. 3, pp. 272–273. doi.org/doi 10.1016/j.ccr.2013.03.004
Kalluri, R. and Weinberg, R.A., The basis of epithelial–mesenchymal transition, J. Clin. Invest., 2009, vol. 119, no. 6, pp. 1420–1428. doi 10.1172/JCI39104
Gostner, J.M., Fong, D., Wrulich, O.A., Lehne, F., Zitt, M., Hermann, M., Krobitsch, S., Martowicz, A., Gastl, G., and Spizzo, G., Effects of EpCAM overexpression on human breast cancer cell lines, BMC Cancer, 2011, vol. 11. doi 10.1186/1471-2407-11-45
De Miguel, M.P., Fuentes-Julian, S., Blazquez-Martinez, A., Pascual, C.Y., Aller, M.A., Arias, J., and Arnalich-Montiel, F., Immunosuppressive properties of mesenchymal stem cells: advances and applications, Curr. Mol. Med., 2012, vol. 12, no. 5, pp. 574–591. doi 10.2174/156652412800619950
Tran, C. and Damaser, M.S., Stem cells as drug delivery methods: Application of stem cell secretome for regeneration, Adv. Drug. Deliv. Rev., 2005, vols. 82–83, pp. 1–11. doi 10.1016/j.addr.2014.10.007
Cortes-Dericks, L., Froment, L., Kocher, G., and Schmid, R.A., Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines, Stem. Cell Res. Ther., 2016, vol. 7. doi 10.1186/s13287-016-0282-7
Gauthaman, K., Yee, F.C., Cheyyatraivendran, S., Biswas, A., Choolani, M., and Bongso, A., Human umbilical cord Wharton’s jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro, J. Cell Biochem., 2012, vol. 113, no. 6, pp. 2027–2039. doi 10.1002/jcb.24073
Fong, C.Y., Biswas, A., Subramanian, A., Srinivasan, A., Choolani, M., and Bongso, A., Human keloid cell characterization and inhibition of growth with human Wharton’s jelly stem cell extracts, J. Cell Biochem., 2014, vol. 115, no. 5, pp. 826–838. doi 10.1002/jcb.24724
Wu, S., Ju, G.Q., Du, T., Zhu, Y.J., and Liu, G.H., Microvesicles derived from human umbilical cord Wharton’s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo, PLoS One, 2013, vol. 8, no. 4. e61366. doi 10.1371/journal.pone.0061366
Tran, S.D., Liu, Y., Xia, D., Maria, O.M., Khalili, S., Wang, R.W., Quan, V.H., Hu, S., and Seuntjens, J., Paracrine effects of bone marrow soup restore organ function, regeneration, and repair in salivary glands damaged by irradiation, PLoS One, 2013, vol. 8, no. 4. e61632. doi 10.1371/journal.pone.0061632
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Ukrainian Text © T. Herheliuk, O. Perepelytsina, L. Ostapchenko, M. Sydorenko, 2018, published in Tsitologiya i Genetika, 2018, Vol. 52, No. 4, pp. 54–67.
About this article
Cite this article
Herheliuk, T., Perepelytsina, O., Ostapchenko, L. et al. The Effect of Multipotent Mesenchymal Stromal Cell Derivatives on the Properties of Breast Cancer Cells in vitro and in vivo. Cytol. Genet. 52, 283–293 (2018). https://doi.org/10.3103/S0095452718040035
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0095452718040035